Secondary Prevention in Lower Extremity Artery Disease Patients: Lipid-Lowering Therapy and Long-Term Guideline Adherence

Figures

• 

  Figure 1. Changes of statin application during hospital treatment. The distribution of statin application is displayed for admission or at ambulatory contact at the angiolocigal outpatient department (dotted bars) and discharge, or after ambulatory presentation at the angiological outpatient department (solid bars), in %. Columns in red display no statin treatment, columns in green display statin treatment (green: atorvastatin, dark green: simvastatin, light green: rosuvastatin, olive: pravastatin, greenish-blue: fluvastatin).

• 

  Figure 2. Changes in statin agents, according to initial treatment at admission. (a) For patients with no statin prescription at admission, the prescription practices at hospital discharge or after presentation as outpatient in the angiological department of our facility with different statins are displayed in %. Of note, 19% received no statin prescription at discharge (red slice). For patients with (b) simvastatin, (c) atorvastatin and (d) rosuvastatin at admission, the prescription practices at hospital discharge or after presentation as outpatient in the angiological department with different statins are displayed in %. Red color display no statin treatment, green colors display statin treatment (green: atorvastatin, dark green: simvastatin, light green: rosuvastatin, olive: other.

• 

  Figure 3. Recommendation of lipid-lowering therapy in the epicrisis of the doctors’ reports. Four different recommendation options are displayed: pharmacological advice (dark green), dietary advice (light green), both pharmacological and dietary advice (green), no advice (red). Values are shown in %.